Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (“Stack Capital” or the “Company”) (TSX: STCK and STCK.WT) today announced its financial results for the three and six months...
-
TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Stack Capital Group Inc. (“Stack Capital”) (TSX: STCK and STCK.WT) is pleased to announce that it has invested $7 million USD into preferred shares of...
-
TORONTO, May 19, 2022 (GLOBE NEWSWIRE) -- Stack Capital Group Inc. (“Stack Capital”) (TSX: STCK and STCK.WT) today announces that at its annual and special meeting of shareholders, held virtually on...
-
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (“Stack Capital” or the “Company”) (TSX: STCK and STCK.WT) today announced its financial results for the first quarter ended March...
-
TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Stack Capital Group Inc. (“Stack Capital”) (TSX: STCK and STCK.WT) is pleased to announce that it has invested $8 million USD into preferred shares of...
-
PLYMOUTH MEETING, Pa., Dec. 08, 2021 (GLOBE NEWSWIRE) -- NW3 Access – a company that acts both as a financial agent for advisors and investors, and as a placement agent for private equity fund...
-
NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, will be hosting...
-
CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing...
-
ST. LOUIS, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers for the...
-
BERN, Switzerland, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers...